期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性硬化的治疗进展

New Advancement In The Treatment of Multipl Scletosis
下载PDF
导出
摘要 目的:总结多发性硬化的近年治疗方法。方法:复习近年来相关资料。结果:各种治疗方法从不同程度上缓解并减轻病残程度。结论:药物治疗方法是目前治疗多发性硬化的有效方法,外周血干细胞移植研究有待进一步发展。 Objective： To summarize the therapeutic methods in treating multiple sclerosis in recent years. Methods：Reviewing related informations in recent years. Results： Many treatments can release the severity of symptoms and reduce the invalidity rate. Conclusion：Drug treatment is effective methods in treatment of multiple sclerosis. The study of peripheral blood stem cell transplantion remains to be further researched.
作者 许文莉 韩英丽
机构地区 赤峰市宝山医院神经内科
出处 《内蒙古医学杂志》 2007年第7期835-837,共3页 Inner Mongolia Medical Journal
关键词 多发性硬化 药物治疗 外周血干细胞移植 Multiple sclerosis（MS） Drug treatment Peripheral blood stem cell transplantion
分类号 R744.51 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献12

  • 1Kieseier BC,Hartung HP.Current disease-modifying Therapies in multiple scierosis[J].Semin Neurot,2003,23(2):133-146.
  • 2The IFNB Mukiple Scterosis Study Group.Interferon beta-lb is effective in retapsing-remitting multiple sclerosis.l.Clinical results of a multicenter,randomized,double-blind,Placebo-contro-lled trial[J].Neurology,1993,43(4):655-661.
  • 3Pozzilli C,Romano S,Cannoni S.Epidemiology and Current treatment of multiple sclerosis in Europe today[J].J Rehabil Res Dev,2002,39(2):175-185.
  • 4Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-la in MS(SPECTRIMS) Study Group.Randomized Controlled trial of interferon-beta-la in secondary progressive MS:Clinical results[J].Neurology,2001,56(11):1496-1504.
  • 5PRISMS(Prevention of Relapses and Disability by Interron-[beta]-la Subcutaneously in Multiple Sclerosis)Study Group.The university of British Cotumbia MS/MRI Analysis Group.PRISMS -4:Long-term efficacy of interferon-beta-la in relapsing MS[J].Neurology,2001,56(12):1628-1636.
  • 6Martinelli Boneschi F,Rovaris M,Johnson KP,et al.Effects of glatiramer acetate on relapse rate and accumulated disability in muttiple sclerosis:met-analyls of three doubte-btind,randomized,ptacebo-controlled clinical trials[J].Muitscler,2003,9(4):349-355
  • 7Neuhaus O,Farina C,Wekerte H,et al.Mechanisms of action of glatiramer acetate in multiple sclerosis[J].Neurology,2001,56(6):702-708.
  • 8孟晓梅,殷剑,张华,冯凯,谢琰臣,王红,许贤豪.环孢素A在神经免疫疾病中的临床应用[J].中国神经免疫学和神经病学杂志,2006,13(1):22-24. 被引量：6
  • 9Durelli L,Isoardo G.Hight-dose intravenous immunoglobulim treatment of multiple sclerosis[J].Neurot Sci,2002,23(suppl):39-48.
  • 10Chris H,Polman,M.D,et al.A Randomized,placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosi s[J].N Engl J med,2006,354:899-910.

二级参考文献17

  • 1姜汉英,林正斌,曾凡军,廖永芳,杨萍,夏穗生.赛斯平免疫抑制作用机理的探讨[J].中华器官移植杂志,1996,17(1):23-24. 被引量：1
  • 2许贤豪.肌无力[M].北京:中国协和医科大学出版社,2003.26,48-75.
  • 3Holt DW, Mueller EA, Kovarik JM,et al. Sandimmune Neoral pharmacokinetics:impact of the new oral formulation[J]. Transpl Proc, 1995,27 : 1434.
  • 4Antonini G, Bove R, Filippini C,et al. Results of an open trial of eyelosporine in a group of steroid-dependent myasthenie subjeets[J]. Clin Neurol Neurosurg, 1990,92:317-321.
  • 5Schalke BCG, Kappos L, Dommasch D,et al. Cyclosporin A (CyA) in the treatment of myasthernia gravis (MG) : A controlled randomized double blind trial cyclosporin A/azathioprine study design and first results [J]. Muscle Nerve, 1986,9(5s) : 157.
  • 6Hartung HP. Suppression of actively induced andpassively transferred experimental allergic neuritis bycyclosporin A [J]. J Neuroimmunol, 1991, al (1)89-90.
  • 7Jolivalt CG, Howard RB, Chen LS,etal. A novel nitrie oxide seavenger in eombination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in miee[J]. J Neuroimmunol,2003, 138(1-2) : 56-64.
  • 8Mahattanakul W, Crawford TO, Griffin JW, et al.Treatment of ehornie inflammatory demyelinating polyneuropathy with eyelosporin-A [J]. J Neurol Neurosurg Psyehiat, 1996,60(2) : 185-187.
  • 9Burdmann EA, Andoh TF, Yu L,etal. Cyclosporine nephrotoxieity[J]. Semin Nephrol, 2003,23 (5): 465- 476.
  • 10O' Keefe SJ, Tamura J, Kincaid RL. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by ealeineurin[J]. Nature, 1992,357:692-694.

共引文献5

内蒙古医学杂志
2007年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部